Hepatitis B Vaccine (Recombinant) Terminated Phase 4 Trials for Human Papillomavirus Infections Prevention

IndicationsStatusPurposePhase
TerminatedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01082861Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination